DRDB: A Machine Learning Platform to Predict Chemical‐Protein Interactions towards Diabetic Retinopathy
Open Access
- 20 July 2022
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2022 (1) , 1718353
Abstract
Diabetic retinopathy (DR), a diabetic microangiopathy caused by diabetes, affects approximately 93 million people, worldwide. However, the drugs used to treat DR have limited efficacy and the variety of side effects. This is possibly because the complicated pathogenesis of DR is associated with multiple proteins. In this work, we attempted to identify potential drugs against DR‐associated proteins and predict potential targets for drugs using in silico prediction of chemical‐protein interactions (CPI) based on multitarget quantitative structure‐activity relationship (mt‐QSAR) method. Therefore, we developed 128 binary classifiers to predict the CPI for 15 DR targets using random forest (RF), k‐nearest neighbours (KNN), support vector machine (SVM), and neural network (NN) algorithms with MACCS, extended connectivity fingerprints (ECFP6) fingerprints, and protein descriptors. In order to facilitate discovery of the novel drugs and target identification using the 128 binary classifiers, a free web server (DRDB) was developed. Compound Danshen Dripping Pills (CDDP), composed of Salvia miltiorrhiza, Panax notoginseng, and borneol, is commonly used in the treatment of cardiovascular diseases. To explore the applicability of DRDB, the potential CPIs of CDDP in treatment of DR were investigated based on DRDB. In vitro experimental validation demonstrated that cryptotanshinone and protocatechuic acid, two key components of CDDP, are capable of targeting ICAM‐1 which is one of the key target of DR. We hope that this work can facilitate development of more effective clinical strategies for the treatment of DR.Keywords
Funding Information
- National Key Research and Development Program of China (2017YFC1104400)
This publication has 32 references indexed in Scilit:
- The ChEMBL bioactivity database: an updateNucleic Acids Research, 2013
- NMR evaluation of total statin content and HMG-CoA reductase inhibition in red yeast rice (Monascus spp.) food supplementsChinese Medicine, 2012
- From in silico target prediction to multi-target drug design: Current databases, methods and applicationsJournal of Proteomics, 2011
- What are artificial neural networks?Nature Biotechnology, 2008
- Screening for and managing diabetic retinopathy: Current approachesAmerican Journal of Health-System Pharmacy, 2007
- Random Forest: A Classification and Regression Tool for Compound Classification and QSAR ModelingJournal of Chemical Information and Computer Sciences, 2003
- Drug Discovery Using Support Vector Machines. The Case Studies of Drug-likeness, Agrochemical-likeness, and Enzyme Inhibition PredictionsJournal of Chemical Information and Computer Sciences, 2003
- A new view of diabetic retinopathy: a neurodegenerative disease of the eyeProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2003
- Novel Variable Selection Quantitative Structure−Property Relationship Approach Based on thek-Nearest-Neighbor PrincipleJournal of Chemical Information and Computer Sciences, 1999
- Microvascular Protection with Calcium Dobesilate (Doxium) in Diabetic RetinopathyOphthalmologica, 1974